QOL-26. A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT IDH1/2DIFFUSE GLIOMA (INDIGO): ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE, NEUROCOGNITION AND SEIZURES

Saved in:
Bibliographic Details
Published inNeuro-oncology (Charlottesville, Va.) Vol. 25; no. Suppl 5; pp. v254 - v255
Main Authors Peters, Katherine, Mellinghoff, Ingo, van den Bent, Martin, Blumenthal, Deborah, Touat, Mehdi, Clarke, Jennifer, Mendez, Joe, Yust-Katz, Shlomit, Mason, Warren, Ducray, Francois, Umemura, Yoshie, Burt Nabors, L, Holdhoff, Matthias, Hottinger, Andreas, Arakawa, Yoshiki, Sepúlveda, Juan, Wick, Wolfgang, Soffietti, Riccardo, Perry, James, Giglio, Pierre, de la Fuente, Macarena, Maher, Elizabeth, Bottomley, Andrew, Zhao, Dan, Pandya, Shuchi, Steelman, Lori, Hassan, Islam, Wen, Patrick, Cloughesy, Timothy
Format Journal Article
LanguageEnglish
Published US Oxford University Press 10.11.2023
Subjects
Quality of Life
Online AccessGet full text
ISSN1522-8517
1523-5866
DOI10.1093/neuonc/noad179.0978

Cover

More Information
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/noad179.0978